← FDA Drug Approvals (Drugs@FDA)
TRI LO SPRINTEC
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR LABS INC · Approved 2009-06-29
Drug application
- FDA Application #
ANDA076784
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRI LO SPRINTEC
- Generic name
- NORGESTIMATE AND ETHINYL ESTRADIOL
- Active ingredients
- ETHINYL ESTRADIOL; NORGESTIMATE
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Prescription
- Sponsor
- BARR LABS INC
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- First approval
- 2009-06-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown